Clinical utility of testing for PALB2and CHEK2c.1100delC in breast and ovarian cancer

MLA

Woodward, Emma R., et al. “Clinical Utility of Testing for PALB2and CHEK2c.1100delC in Breast and Ovarian Cancer.” Genetics in Medicine, vol. 23, no. 10, Oct. 2021, pp. 1969–76. EBSCOhost, https://doi.org/10.1038/s41436-021-01234-6.

APA

Woodward, E. R., van Veen, E. M., Forde, C., Harkness, E. F., Byers, H. J., Ellingford, J. M., Burghel, G. J., Schlech, H., Bowers, N. L., Wallace, A. J., Howell, S. J., Howell, A., Lalloo, F., Newman, W. G., Smith, M. J., & Gareth Evans, D. (2021). Clinical utility of testing for PALB2and CHEK2c.1100delC in breast and ovarian cancer. Genetics in Medicine, 23(10), 1969–1976. https://doi.org/10.1038/s41436-021-01234-6

Chicago

Woodward, Emma R., Elke M. van Veen, Claire Forde, Elaine F. Harkness, Helen J. Byers, Jamie M. Ellingford, George J. Burghel, et al. 2021. “Clinical Utility of Testing for PALB2and CHEK2c.1100delC in Breast and Ovarian Cancer.” Genetics in Medicine 23 (10): 1969–76. doi:10.1038/s41436-021-01234-6.